-
2023-509891-40-00
5
2026-04-28
Pulmonary arterial hypertension
-
2023-507801-32-00
6
2026-04-22
Isolated Subsegmental Pulmonary Embolism
-
2024-520205-39-00
5
2026-04-21
Traumatic brain injury
-
2024-520238-31-01
9
2026-04-20
Advanced Lung Cancer
-
2023-506611-17-00
9
2026-04-16
Advanced liver cancers
-
2025-521012-18-00
5
2026-04-13
Facioscapulohumeral Muscular Dystrophy (FSHD)
-
2025-523085-24-00
5
2026-04-13
Biliary Tract Cancer
-
2024-517674-23-00
5
2026-04-09
Subjects undergoing elective endovascular coiling-only repair of unrup
-
2025-523263-37-00
10
2026-04-08
Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal
-
2024-510942-15-00
5
2026-04-07
Cancer surgery
-
2025-523013-28-00
4
2026-04-07
Endocrine-Resistant Hormone-Receptor-Positive, HER2-Negative Advanced
-
2024-519208-29-00
4
2026-04-02
Pleural mesothelioma
-
2024-520101-39-00
5
2026-04-01
TROP2 NMR-positive advanced or metastatic non-squamous non-small cell
-
2025-523224-45-00
10
2026-03-30
Untreated, Unresectable or Metastatic Colorectal Cancer
-
2025-522544-40-00
5
2026-03-27
Hereditary transthyretin-mediated amyloidosis with polyneuropathy
-
2024-513401-31-00
5
2026-03-24
Septic shock
-
2025-521036-11-00
5
2026-03-23
Immune system disseases
-
2025-522533-54-00
4
2026-03-17
Metastatic Non-small cell lung cancer (NSCLC) and Pancreatic ductal ad
-
2025-521621-33-00
6
2026-03-16
Melanoma
-
2024-516643-64-00
5
2026-03-13
Aortic bioprothesis implanted patient for valvular heart disease
-
2025-521284-12-00
5
2026-03-05
Non-small cell lung cancer
-
2025-521642-14-00
4
2026-03-05
Multiple System Atrophy
-
2023-506291-28-00
5
2026-03-02
Patient with locally advanced/metastatic, MSI-H/dMMR gastric cancer
-
2025-521035-37-00
5
2026-03-02
Immune system diseases